Core Insights - Bank of Nova Scotia (BNS) is well-positioned to continue its earnings-beat streak in upcoming reports, with a history of surpassing earnings estimates, particularly in the last two quarters, averaging a surprise of 5.77% [1] Earnings Performance - In the last reported quarter, Bank of Nova Scotia achieved earnings of $1.39 per share, exceeding the Zacks Consensus Estimate of $1.33 per share, resulting in a surprise of 4.51% [2] - For the previous quarter, the company was expected to report earnings of $1.28 per share but delivered $1.37 per share, yielding a surprise of 7.03% [2] Earnings Estimates and Predictions - Recent estimates for Bank of Nova Scotia have been trending upward, with a positive Earnings ESP (Expected Surprise Prediction) indicating a strong potential for an earnings beat, especially given its favorable Zacks Rank [5] - Stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have a nearly 70% chance of producing a positive surprise, suggesting that out of 10 such stocks, approximately seven could beat consensus estimates [6] Earnings ESP and Analyst Sentiment - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions, which may be more accurate [7] - Currently, Bank of Nova Scotia has an Earnings ESP of +0.12%, indicating increased analyst optimism regarding its near-term earnings potential, combined with a Zacks Rank of 2 (Buy), suggesting a likely earnings beat [8] Upcoming Earnings Report - The next earnings report for Bank of Nova Scotia is anticipated to be released on February 24, 2026 [8]

Core Insights - Teladoc Health, Inc. (TDOC) is expected to report a fourth-quarter 2025 loss of 19 cents per share on revenues of $633.91 million, with a year-over-year revenue decrease of 1% [1][2][7] Financial Performance - The fourth-quarter earnings estimate has improved by a penny over the past 60 days, indicating a year-over-year improvement of 32.1% in the bottom line [2] - For the full year 2025, the Zacks Consensus Estimate for Teladoc's revenues is $2.52 billion, reflecting a decline of 1.9% year over year, while the EPS estimate is a loss of $1.20, showing an improvement of 79.6% year over year [3] Earnings Expectations - Teladoc has beaten earnings estimates in three of the last four quarters, with an average surprise of 14.5% [3] - The company has an Earnings ESP of 0.00% and a Zacks Rank of 2 (Buy), which does not conclusively predict an earnings beat this time [4] Segment Performance - Integrated Care members are expected to increase by 9.1%, with segment EBITDA rising by 20.9% year over year [7][10] - BetterHelp revenue is projected to decline by 6.2%, with paying users down by 5% in Q4, and the adjusted EBITDA from this segment is expected to fall by 28.9% year over year [9][10] Revenue Breakdown - The Zacks Consensus Estimate for fourth-quarter Access fees revenues indicates a 1.3% year-over-year decline, while U.S. operations are expected to have declined, partially offset by increased revenues from international operations [8] - Overall adjusted EBITDA is expected to be between $73 million and $90 million, with free cash flow for the full year 2025 projected to be between $170 million and $185 million [10]

Core Viewpoint - Entrada Therapeutics, Inc. (TRDA) is anticipated to report a significant year-over-year decline in earnings and revenues for the quarter ended December 2025, which could impact its stock price depending on the actual results compared to estimates [1][3]. Earnings Expectations - The consensus estimate indicates a quarterly loss of $1.32 per share, reflecting a drastic year-over-year change of -4500% [3]. - Expected revenues are projected at $1.29 million, down 96.6% from the same quarter last year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 1.52%, indicating a reassessment by analysts regarding the company's earnings prospects [4]. - The Most Accurate Estimate for Entrada Therapeutics is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -59.09%, suggesting a bearish outlook from analysts [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the deviation of actual earnings from consensus estimates, but it is more reliable for positive readings [9][10]. - The current Zacks Rank for Entrada Therapeutics is 3, which complicates the prediction of an earnings beat [12]. Historical Performance - In the last reported quarter, Entrada Therapeutics was expected to post a loss of $1.04 per share but actually reported a loss of -$1.06, resulting in a surprise of -1.92% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates twice [14]. Conclusion - Overall, Entrada Therapeutics does not appear to be a strong candidate for an earnings beat, and investors should consider other factors before making investment decisions [17].

Company Overview - Marcus (MCS) is expected to report a year-over-year decline in earnings, with a projected earnings per share (EPS) of $0.07, reflecting a decrease of 46.2% compared to the previous year [3] - Revenues for the quarter are anticipated to be $184.56 million, which is a 2% decline from the same quarter last year [3] Earnings Expectations - The earnings report is scheduled for release on February 26, and if the results exceed expectations, the stock may experience an upward movement; conversely, missing expectations could lead to a decline [2] - The consensus EPS estimate has been revised 2.14% higher in the last 30 days, indicating a reassessment by analysts [4] Earnings Surprise Prediction - The Zacks Earnings ESP (Expected Surprise Prediction) model indicates that the Most Accurate Estimate for Marcus is the same as the Zacks Consensus Estimate, resulting in an Earnings ESP of 0% [12] - The stock currently holds a Zacks Rank of 4 (Sell), complicating predictions of an earnings beat [12] Historical Performance - In the last reported quarter, Marcus was expected to post earnings of $0.43 per share but delivered $0.42, resulting in a surprise of -2.33% [13] - Over the past four quarters, the company has beaten consensus EPS estimates two times [14] Industry Context - In the Zacks Leisure and Recreation Services industry, Life Time Group Holdings, Inc. (LTH) is expected to report earnings of $0.32 per share, reflecting a year-over-year increase of 18.5% [18] - Life Time Group Holdings anticipates revenues of $740.38 million, which is an 11.6% increase from the previous year [18] - Despite a recent downward revision of 1.5% in the consensus EPS estimate for Life Time Group Holdings, it has an Earnings ESP of +6.35% [19]

Core Viewpoint - The market anticipates TeraWulf Inc. (WULF) will report a year-over-year decline in earnings despite higher revenues in its upcoming earnings report for the quarter ended December 2025 [1] Earnings Expectations - The consensus EPS estimate for TeraWulf is a loss of $0.13 per share, reflecting a year-over-year decline of 62.5% [3] - Expected revenues are projected at $43.55 million, which is an increase of 24.5% compared to the same quarter last year [3] Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 0.95%, indicating a reassessment by analysts regarding the company's earnings prospects [4] - The Most Accurate Estimate for TeraWulf is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -41.79%, suggesting a bearish outlook from analysts [12] Earnings Surprise Prediction - A positive Earnings ESP is generally a strong indicator of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [10] - TeraWulf currently holds a Zacks Rank of 2, but the negative Earnings ESP complicates predictions of an earnings beat [12] Historical Performance - In the last reported quarter, TeraWulf was expected to post a loss of $0.04 per share but actually reported a loss of $0.07, resulting in a surprise of -75.00% [13] - The company has not exceeded consensus EPS estimates in any of the last four quarters [14]

Wall Street expects a year-over-year increase in earnings on lower revenues when Energy Fuels (UUUU) reports results for the quarter ended December 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on February 26, might help the stock move higher if these key numbers are better than expec ...

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Vistra Corp. (VST) due to higher revenues, with a focus on how actual results compare to estimates impacting stock price [1] Earnings Expectations - The upcoming earnings report is expected to show quarterly earnings of $2.51 per share, reflecting a year-over-year increase of +120.2% [3] - Revenues are projected to be $5.34 billion, which is an increase of 32.3% from the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised 5.46% higher in the last 30 days, indicating a reassessment by analysts [4] - However, the Most Accurate Estimate for Vistra is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -48.87%, suggesting a bearish outlook from analysts [12] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict deviations from consensus estimates, but it is more reliable for positive readings [9][10] - Vistra's current Zacks Rank is 3, which complicates predictions of an earnings beat [12] Historical Performance - In the last reported quarter, Vistra exceeded expectations with earnings of $1.75 per share against an estimate of $1.20, resulting in a surprise of +45.83% [13] - Over the past four quarters, Vistra has beaten consensus EPS estimates two times [14] Conclusion - Despite the potential for an earnings beat, Vistra does not appear to be a compelling candidate for a significant positive surprise, and investors should consider other factors before making decisions [17]

Core Viewpoint - The market anticipates MP Materials Corp. (MP) to report a year-over-year increase in earnings despite lower revenues for the quarter ending December 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - The consensus estimate for MP Materials is an earnings per share (EPS) of $0.04, reflecting a year-over-year increase of +133.3%. However, revenues are projected to decline by 2.3% to $59.6 million compared to the same quarter last year [3]. Estimate Revisions - Over the past 30 days, the consensus EPS estimate has been revised down by 23.53%, indicating a bearish sentiment among analysts regarding the company's earnings prospects [4]. Earnings Surprise Prediction - The Most Accurate Estimate for MP Materials is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -127.27%. This suggests a challenging outlook for the company to exceed the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, MP Materials was expected to post a loss of $0.14 per share but delivered a smaller loss of -$0.10, resulting in a positive surprise of +28.57%. Over the last four quarters, the company has beaten consensus EPS estimates twice [13][14]. Overall Assessment - MP Materials does not currently appear to be a strong candidate for an earnings beat, and investors are advised to consider other factors when making decisions regarding the stock ahead of the earnings release [17].

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Curaleaf Holdings, Inc. due to lower revenues, with a focus on how actual results will compare to estimates [1][2]. Earnings Expectations - Curaleaf is expected to report a quarterly loss of $0.08 per share, reflecting a significant year-over-year change of -500% [3]. - Revenues are projected to be $327.84 million, which is a decrease of 1% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 2.22% over the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Curaleaf is lower than the Zacks Consensus Estimate, leading to an Earnings ESP of -3.23% [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from consensus estimates, with a strong predictive power for positive readings [7][8]. - Curaleaf's current Zacks Rank is 4, which complicates the prediction of an earnings beat [11]. Historical Performance - In the last reported quarter, Curaleaf was expected to post a loss of $0.07 per share but actually reported a loss of -$0.06, resulting in a surprise of +14.29% [12]. - Over the past four quarters, Curaleaf has beaten consensus EPS estimates three times [13]. Conclusion - Curaleaf Holdings, Inc. does not appear to be a strong candidate for an earnings beat, and investors should consider other factors when making decisions regarding the stock ahead of the earnings release [16].

Core Insights - GoDaddy (GDDY) is set to report its fourth-quarter 2025 results on February 24, with expected revenues between $1.26 billion and $1.28 billion, indicating a 6% growth at the mid-point compared to the previous year [2][10] - The Zacks Consensus Estimate for fourth-quarter revenues is $1.27 billion, suggesting a 6.39% year-over-year increase, while the consensus for earnings is $1.58 per share, reflecting an 11.27% growth from the prior year's figure [3] Revenue Expectations - GoDaddy anticipates Applications & Commerce (A&C) revenue growth in the low to mid-teens, with A&C revenues estimated at $499.1 million, indicating a 13.1% year-over-year rise [5] - Core platform revenues are expected to reach $769.5 million, suggesting a 2.4% year-over-year growth [5] Business Drivers - The company is expected to benefit from strong adoption of high-margin subscriptions, including GoDaddy Capital, Rate Saver, and Faster Payouts, which are designed to help entrepreneurs streamline operations and reduce costs [6] - GoDaddy Airo and Ask Airo tools are driving better attachment rates, higher average order sizes, and improved retention, with bookings estimated at $1.31 billion, suggesting a 6.8% year-over-year growth [7][10] Challenges - Despite positive growth indicators, GoDaddy faces challenges such as macroeconomic conditions, foreign exchange impacts, contract expirations, and customer renewal headwinds [7][10] Earnings Outlook - According to the Zacks model, GoDaddy currently has an Earnings ESP of 0.00% and a Zacks Rank of 2, indicating a moderate outlook for an earnings beat [8]